Cooperating mutations of receptor tyrosine kinases and Ras genes in childhood core-binding factor acute myeloid leukemia and a comparative analysis on paired diagnosis and relapse samples
- PMID: 17960171
- DOI: 10.1038/sj.leu.2404995
Cooperating mutations of receptor tyrosine kinases and Ras genes in childhood core-binding factor acute myeloid leukemia and a comparative analysis on paired diagnosis and relapse samples
Abstract
c-KIT mutations have been described in core-binding factor (CBF) acute myeloid leukemia (AML) at diagnosis. The role of c-KIT mutations in the relapse of CBF-AML is not clear. The role of CSF1R mutation in the pathogenesis of AML remains to be determined. We analyzed receptor tyrosine kinases (RTKs) and Ras mutations on 154 children with AML. Also, we examined the paired diagnosis and relapse samples in CBF-AML. CBF-AML accounted for 27% (41/154). c-KIT mutations were detected in 41.5% of CBF-AML at diagnosis (6 in exon 8, 10 in exon 17 and 1 in both exons 8 and 17) , FLT3-TKD 2.7%, N-Ras mutations 7.3% and K-Ras mutations 4.9%. FLT3-LM and CSF1R mutations were not found in CBF-AML. The mutations of RTKs and Ras were mutually exclusive except for one patient who had both c-KIT and N-Ras mutations. Eight of the 41 CBF-AML patients relapsed; four patients retained the identical c-KIT mutation patterns as those at diagnosis, the remaining four without c-KIT mutations at diagnosis did not acquire c-KIT mutations at relapse. Our study showed that 54% of childhood CBF-AML had RTKs and/or Ras mutations; c-KIT but not CSF1R mutations play a role in the leukemogenesis of childhood CBF-AML.
Similar articles
-
[Analysis of tyrosine kinases gene mutations in core binding factor related acute myeloid leukemia and its clinical significance].Zhonghua Xue Ye Xue Za Zhi. 2011 Oct;32(10):679-83. Zhonghua Xue Ye Xue Za Zhi. 2011. PMID: 22339826 Chinese.
-
Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia.Leukemia. 2005 Sep;19(9):1536-42. doi: 10.1038/sj.leu.2403870. Leukemia. 2005. PMID: 16015387
-
Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML).Leukemia. 2006 Jun;20(6):965-70. doi: 10.1038/sj.leu.2404188. Leukemia. 2006. PMID: 16598313
-
FLT3 length mutations as marker for follow-up studies in acute myeloid leukaemia.Acta Haematol. 2004;112(1-2):68-78. doi: 10.1159/000077561. Acta Haematol. 2004. PMID: 15179006 Review.
-
Pathogenesis of acute myeloid leukaemia and inv(16)(p13;q22): a paradigm for understanding leukaemogenesis?Br J Haematol. 2005 Jan;128(1):18-34. doi: 10.1111/j.1365-2141.2004.05236.x. Br J Haematol. 2005. PMID: 15606546 Review.
Cited by
-
Single nucleotide polymorphism genomic arrays analysis of t(8;21) acute myeloid leukemia cells.Haematologica. 2009 Sep;94(9):1301-6. doi: 10.3324/haematol.2009.005744. Haematologica. 2009. PMID: 19734423 Free PMC article.
-
Genetic tests to evaluate prognosis and predict therapeutic response in acute myeloid leukemia.J Mol Diagn. 2010 Jan;12(1):3-16. doi: 10.2353/jmoldx.2010.090054. Epub 2009 Dec 3. J Mol Diagn. 2010. PMID: 19959801 Free PMC article. Review.
-
Core-binding factor acute myeloid leukemia in pediatric patients enrolled in the AIEOP AML 2002/01 trial: screening and prognostic impact of c-KIT mutations.Leukemia. 2014 May;28(5):1132-4. doi: 10.1038/leu.2013.339. Epub 2013 Nov 14. Leukemia. 2014. PMID: 24226631 Clinical Trial. No abstract available.
-
Functional Properties of KIT Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid Leukemia.Clin Cancer Res. 2019 Aug 15;25(16):5038-5048. doi: 10.1158/1078-0432.CCR-18-1897. Epub 2019 Jun 10. Clin Cancer Res. 2019. PMID: 31182436 Free PMC article.
-
A high occurrence of acquisition and/or expansion of C-CBL mutant clones in the progression of high-risk myelodysplastic syndrome to acute myeloid leukemia.Neoplasia. 2011 Nov;13(11):1035-42. doi: 10.1593/neo.111192. Neoplasia. 2011. PMID: 22131879 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous